Adirondack Trust CO Becton Dickinson & CO Transaction History

Adirondack Trust CO

  • $297 Million
  • Q4 2025

A detailed history of Adirondack Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Adirondack Trust CO holds 958 shares of BDX stock, worth $182,958. This represents 0.06% of its overall portfolio holdings.

Number of Shares
958
Previous 968 1.03%
Holding current value
$182,958
Previous $181,000 0.55%
% of portfolio
0.06%
Previous 0.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026
SELL
$176.39 - $193.93 $1,763 - $1,939
-10 Reduced 1.03%
958 $182,000
Q3 2025

Oct 20, 2025
SELL
$172.41 - $199.66 $17,241 - $19,966
-100 Reduced 9.36%
968 $181,000
Q2 2025

Jul 11, 2025
SELL
$165.15 - $226.42 $4,128 - $5,660
-25 Reduced 2.29%
1,068 $183,000
Q1 2025

Apr 03, 2025
SELL
$222.79 - $249.08 $7,574 - $8,468
-34 Reduced 3.02%
1,093 $250,000
Q4 2024

Jan 17, 2025
SELL
$220.02 - $243.75 $5,280 - $5,850
-24 Reduced 2.09%
1,127 $255,000
Q3 2024

Oct 08, 2024
SELL
$221.47 - $242.41 $11,516 - $12,605
-52 Reduced 4.32%
1,151 $277,000
Q2 2024

Jul 09, 2024
SELL
$225.07 - $246.17 $1,575 - $1,723
-7 Reduced 0.58%
1,203 $281,000
Q1 2024

Apr 09, 2024
SELL
$233.45 - $247.73 $700 - $743
-3 Reduced 0.25%
1,210 $299,000
Q4 2023

Mar 29, 2024
SELL
$232.24 - $267.23 $928 - $1,068
-4 Reduced 0.33%
1,213 $295,000
Q3 2023

Oct 31, 2023
SELL
$254.9 - $283.59 $6,627 - $7,373
-26 Reduced 2.09%
1,217 $314,000
Q2 2023

Aug 09, 2023
SELL
$238.39 - $265.32 $953 - $1,061
-4 Reduced 0.32%
1,243 $328,000
Q1 2023

Apr 28, 2023
SELL
$229.71 - $259.35 $37,902 - $42,792
-165 Reduced 11.69%
1,247 $308,000
Q4 2022

Jan 13, 2023
SELL
$218.29 - $256.91 $436 - $513
-2 Reduced 0.14%
1,412 $0
Q3 2022

Oct 13, 2022
SELL
$51.03 - $264.23 $6,480 - $33,557
-127 Reduced 8.24%
1,414 $315,000
Q2 2022

Jul 06, 2022
SELL
$234.74 - $275.42 $22,300 - $26,164
-95 Reduced 5.81%
1,541 $380,000
Q1 2022

Apr 05, 2022
SELL
$243.64 - $270.48 $8,527 - $9,466
-35 Reduced 2.09%
1,636 $435,000
Q4 2021

Jan 13, 2022
SELL
$230.08 - $250.94 $181,763 - $198,242
-790 Reduced 32.1%
1,671 $420,000
Q3 2021

Nov 16, 2021
SELL
$232.72 - $256.47 $1,861 - $2,051
-8 Reduced 0.32%
2,461 $590,000
Q1 2021

Apr 16, 2021
SELL
$232.09 - $256.88 $2,320 - $2,568
-10 Reduced 0.4%
2,469 $600,000
Q4 2020

Feb 12, 2021
SELL
$221.92 - $245.94 $24,633 - $27,299
-111 Reduced 4.29%
2,479 $649,000
Q3 2020

Oct 05, 2020
SELL
$215.77 - $276.76 $2,157 - $2,767
-10 Reduced 0.38%
2,590 $603,000
Q2 2020

Aug 19, 2020
SELL
$219.9 - $263.41 $32,985 - $39,511
-150 Reduced 5.45%
2,600 $731,000
Q1 2020

Apr 23, 2020
BUY
$195.69 - $279.01 $89,038 - $126,949
455 Added 19.83%
2,750 $632,000
Q4 2019

Feb 11, 2020
BUY
$236.45 - $266.82 $108,294 - $122,203
458 Added 24.93%
2,295 $632,000
Q3 2019

Oct 09, 2019
BUY
$230.58 - $256.08 $1,152 - $1,280
5 Added 0.27%
1,837 $464,000
Q1 2019

May 13, 2019
SELL
$206.05 - $248.17 $33,998 - $40,948
-165 Reduced 8.26%
1,832 $441,000
Q4 2018

Jan 18, 2019
BUY
$204.73 - $257.93 $5,527 - $6,964
27 Added 1.37%
1,997 $450,000
Q3 2018

Oct 22, 2018
SELL
$233.07 - $256.0 $3,496 - $3,840
-15 Reduced 0.76%
1,970 $514,000
Q2 2018

Jul 26, 2018
SELL
$208.1 - $233.85 $4,162 - $4,677
-20 Reduced 1.0%
1,985 $475,000
Q1 2018

May 03, 2018
SELL
$205.46 - $240.27 $3,081 - $3,604
-15 Reduced 0.74%
2,005 $465,000
Q4 2017

Jan 10, 2018
SELL
$189.0 - $222.64 $21,735 - $25,603
-115 Reduced 5.39%
2,020 $433,000
Q3 2017

Oct 12, 2017
BUY
$186.89 - $198.9 $399,010 - $424,651
2,135
2,135 $418,000

Others Institutions Holding BDX

# of Institutions
1,716
Shares Held
257M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email